Davita Clinical Research
Baseline Serum Alkaline Phosphatase >100 IU/L Is Associated with Increased Death Risk in Diverse Subgroups of Maintenance Hemodialysis Patients
  • Home >
  • About Us >
    • Leadership >
    • Careers >
      • Our Culture >
      • Diversity & Belonging >
    • Our History >
    • Awards and Recognition >
  • Services >
    • Late Phase Renal Research (ESKD) >
    • Alliance Site Network >
    • International Trials >
  • News >
    • Press Releases >
    • Events >
  • Resources >
    • Blog >
    • Video Library >
  • Contact Us >
    • For Sponsors >
    • For Investigators >
    • For Participants >
  • Home
  • About Us
    • Leadership
    • Careers
      • Our Culture
      • Diversity & Belonging
    • Our History
    • Awards and Recognition
  • Services
    • Late Phase Renal Research (ESKD)
    • Alliance Site Network
    • International Trials
  • News
    • Press Releases
    • Events
  • Resources
    • Blog
    • Video Library
  • Contact Us
    • For Sponsors
    • For Investigators
    • For Participants
  • Search this site

  • Home
  • Baseline Serum Alkaline Phosphatase >100 IU/L Is Associated with Increased Death Risk in Diverse Subgroups of Maintenance Hemodialysis Patients

Baseline Serum Alkaline Phosphatase >100 IU/L Is Associated with Increased Death Risk in Diverse Subgroups of Maintenance Hemodialysis Patients

Posted by:

Regidor DL , Kovesdy CP, Jing J, McAllister CJ , Kopple JD, Kalantar-Zadeh K. Baseline Serum Alkaline Phosphatase Is Associated with Increased Death Risk in Diverse Subgroups of Maintenance Hemodialysis… Read more

Iron Saturation Ratio above 30% Is Associated with Improved ESA Responsiveness in Maintenance Hemodialysis Patients.

Posted by:

Regidor DL, Kopple JD, McAllister CL, Kalantar-Zadeh K. Iron Saturation Ratio above 30% Is Associated with Improved ESA Responsiveness in Maintenance Hemodialysis Patients. American Society of Nephrology Renal Week. San… Read more

Survival Advantages of Hispanic Ethnicity in Maintenance Hemodialysis Patients: Hispanic Paradox within Paradox?

Posted by:

Streja E, Kopple JD, Kovesdy CP , Regidor DL ,McAllister CJ, Kalantar-Zadeh K. Survival Advantages of Hispanic Ethnicity in Maintenance Hemodialysis Patients: Hispanic Paradox within Paradox? American Society of Nephrology… Read more

Is High Platelet Count Responsible for Increased Death Risk in Dialysis Patients with Hemoglobin >13 g/dL?]

Posted by:

Streja E, Kopple JD, Kovesdy CP, McAllister CJ, Nissenson AR, Kalantar-Zadeh K. Is High Platelet Count Responsible for Increased Death Risk in Dialysis Patients with Hemoglobin >13 g/dL? American Society… Read more

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor

Posted by:

Bergman AJ, Cote J, Yi B, Marbury T, Swan SK, Smith W, et al. Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor. Diabetes Care. 2007;30(7):1862-1864. Read more

The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment

Posted by:

Dhaun N, Melville V, Kramer W, Stavros F, Coyne T, Swan S, et al. Br J Clin Pharmacol. 2007;64(6):733-737. Read more

Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiency

Posted by:

Gupta SK, Swan SK, Marbury T, Smith W, Schwartz S, Kolz K, Cutler DL. Br J Clin Pharmacol. 2007;64(6):726-732. Read more

Hepatitis C virus and death risk in hemodialysis patients

Posted by:

Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S. J Am Soc Nephrol 2007;18:1584-1593. Read more

HDL-inflammatory index correlates with poor outcome in hemodialysis patients

Posted by:

Kalantar-Zadeh K, Kopple JD, Kamranpour N, Fogelman AM, Navab M. Kidney Int. 2007;72(9):1149-56. Read more

A1C and survival in maintenance hemodialysis patients

Posted by:

Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K.  Diabetes Care. 2007;30:1049-1055. Read more

Categories

  • Blog
  • Events
  • Press Releases
  • Video

Blog: A Guide to Different Models of SMOs

Navigate
  • Home
  • About Us
  • Services
  • News
  • Resources
  • Contact Us
Headquarters
DaVita Clinical Research®
6600 France Ave S Suite 660
Edina, MN 55435 (Map)
  • Telephone: 888-345-2567
  • Fax: 866-852-3241
Corporate
  • Careers
  • davita.com
  • mykidneyresearch.com
  • Renal Research FAQ
Follow us on:
  • LinkedIn
  • Twitter
  • YouTube
  • Facebook
  • © 2026 DaVita Inc.
  • Web privacy policy
  • Sitemap
  • Terms of use
x
x

View PDF